CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,489 | -46.4% | 70,883 | -16.0% | 0.00% | 0.0% |
| Q2 2023 | $193,203 | -16.4% | 84,368 | -0.6% | 0.00% | -50.0% |
| Q2 2020 | $231,000 | +27.6% | 84,918 | -0.8% | 0.00% | 0.0% |
| Q1 2020 | $181,000 | -59.3% | 85,604 | +4.7% | 0.00% | -33.3% |
| Q4 2019 | $445,000 | +97.8% | 81,800 | +9.5% | 0.00% | +50.0% |
| Q3 2019 | $225,000 | -6.6% | 74,725 | +16.2% | 0.00% | 0.0% |
| Q2 2019 | $241,000 | +1.7% | 64,325 | +9.1% | 0.00% | 0.0% |
| Q1 2019 | $237,000 | +29.5% | 58,951 | +18.3% | 0.00% | +100.0% |
| Q4 2018 | $183,000 | -55.8% | 49,850 | +3.3% | 0.00% | -50.0% |
| Q3 2018 | $414,000 | -20.8% | 48,250 | +1.4% | 0.00% | -33.3% |
| Q2 2018 | $523,000 | +1.6% | 47,600 | +6.5% | 0.00% | 0.0% |
| Q1 2018 | $515,000 | +56.5% | 44,700 | +40.6% | 0.00% | +50.0% |
| Q4 2017 | $329,000 | -23.8% | 31,800 | +17.3% | 0.00% | -33.3% |
| Q3 2017 | $432,000 | +59.4% | 27,100 | +21.0% | 0.00% | +50.0% |
| Q2 2017 | $271,000 | – | 22,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |